
REGISTRATION GUIDELINE
| Virtual and physical participation are available.
For physical attendees, please register in advance to reserve your seat. For virtual attendees, please register to receive the Zoom link. The event is held under the Chatham House Rule. Images from the event may be used for AmCham Vietnam – HCMC’s post-event information, marketing and promotional purposes. The personal information provided to us will only be used for event registration and administration. By registering for this event, you agree and consent to the above. |
Event Description
Vietnam’s healthcare industry—especially the clinic and hospital segment—is entering a period of rapid transformation driven by rising demand, demographic shifts, and strong investor interest. As the market expands, both local and international investors are seeking clearer insights into opportunities, risks, and regulatory pathways.
This event brings together leading investors, healthcare operators, legal and tax experts, and technology innovators to provide a comprehensive overview of the current landscape and future direction of healthcare investments in Vietnam.
Attendees will gain:
- Market Trends & Outlook: An updated analysis of growth drivers, patient demand, competitive dynamics, and the evolving role of private healthcare
- AI in Healthcare: Practical applications of artificial intelligence in clinical operations, diagnostics, and patient management, and how technology is reshaping investment priorities.
- Legal & Tax Guidance: Essential updates on licensing, ownership structures, compliance requirements, M&A considerations, and tax implications for healthcare projects.
Whether you are an investor, operator, advisor, or policymaker, this session will equip you with the knowledge needed to navigate one of Vietnam’s most promising—and complex—sectors.
Join us for an in-depth discussion on unlocking sustainable growth and high-impact investment opportunities in Vietnam’s healthcare market.
![]() |
| 8:30 AM | Registration & Refreshment |
| 9:00 AM | Welcome remarks by AmCham |
| 9:05 AM | Keynote speech: Healthcare Market Landscape, Trends and Future Outlook
Dr. Su Le, CEO, Xuyen A Hospital Group (Former CEO of Vinmec Central Park, Former Group CEO Hoan My) |
| 9:25 AM | Strategic Perspectives: Investment, Innovation & Regulation in Healthcare:
|
| 10:10 AM | Panel discussion and Q&A: Healthcare in Transition: Investment, Innovation and Regulatory Pathways
Moderator: Laurent Nguyen, Partner, Financial Advisory, Forvis Mazars Panelists:
|
| 11:00 AM | Event ends |
| Physical attendees
AmCham Members: VND 650,000 Non-members: VND 850,000 |
Virtual attendees
AmCham Members: VND 200,000 Non-members: VND 400,000 |
| Reservations/cancellations must be received by 24 hours before the event, and must be made on-line or by email. We are unable to accept reservations/cancellations by telephone. | |
Dr. Su Le
CEO, Xuyen A Hospital Group (Former CEO of Vinmec Central Park, Former Group CEO Hoan My) Dr. Le Quoc Su, MD, PhD., currently is CEO of Trans-Asia Hospital System. Before that he employed by STEMBS Holding Company as General Director. Previously Dr. Su was CEO of Vinmec Central Park Hospital. Dr. Su used to hold the position of CEO at City International Hospital. At Hoan MY Medical Corporation, he worked as CEO of Hoan My Sai Gon Hospital and then GCEO. Before working at Hoan My Corporation, Dr. Su held the position of CEO at University Medical Center – Hoang Anh Gia Lai. Dr. Su also worked for Fortis Hoan My Medical Corporations as GCOO. Dr. Su had 7 years working as Country Manager Vietnam for Baxter Healthcare and Abbott Laboratories. He had 3 years working at The Oncology Hospital in HCMC while being Lecturer at Pham Ngoc Thach’ s School of Medicine for 12 years. Dr. Su completed MBA, Executive Program in Viet Nam from the University of Hawaii at Manoa, in 2011. Additionally, Su received a Ph.D in Medicine, in 2003, and Medical Doctor, in 1993 from the University of Medicine and Pharmacy in Ho Chi Minh City |
Zig Wronsky
Manager, Tremont Capital Ventures (Kindred, HonestDocs, DiaB & Nhi Dong 315) Zig Wronsky is the manager of Tremont Capital Ventures, an investment holding company with a healthcare portfolio comprising Kindred Health (Philippines,) HonestDocs (Thailand,) DiaB (Vietnam,) and Nhi Dong 315 (Vietnam.) Prior to Tremont, he served as Vice Director at Nhi Dong 315, where he supported capital raising activities. Before joining Nhi Dong 315, he was an investor at Hendale Capital, a China-outbound growth equity platform based in Hong Kong. At Hendale, Zig originated the firm’s consumer investments in Southeast Asia. He started his career at Boston Millennia Partners, a growth equity firm focusing on healthcare, life sciences, and pharma services. At Boston Millennia Partners, he supported the firm’s investments in Collegium Pharmaceutical (NASDAQ: COLL) and PreCision Dermatology (acquired by Valeant.) Zig holds a BA in Economics and Psychology from Tufts University and an MBA from the University of Chicago. |
Prithvi Puttaraju
CEO & Founder, Cognisian AI Healthcare Prithvi Puttaraju is a seasoned serial technology entrepreneur and business leader with over 35 years of experience building and scaling global tech companies across Silicon Valley, Europe, and Asia. Prithvi has successfully led and exited multiple multi-million-dollar ventures and works closely with investors, boards, and senior executives on growth strategy, digital transformation, policies, and market expansion in regulated industries. His cross-market experience positions him uniquely at the intersection of healthcare innovation, investment strategy, and business execution. Presently, he is the Founder & CEO of Cognisian, an AI-driven healthcare platform that is disrupting healthcare in Southeast Asia by uprooting admin overheads, driving throughput, profitability, and closely monitoring compliance. |
Dao Thu Nga
Head of Public Affairs & Market Access, Sanofi Vietnam Dao Thu Nga is Head of Public Affairs and Market Access at Sanofi Indochina, with over 15 years of experience in the pharmaceutical industry. Works closely with government and regulatory stakeholders across the healthcare system on policy dialogue, reimbursement and market access strategies and initiatives, contributing to sustainable value growth and improved patient access. Holds a Master’s in Marketing and an MBA from ESCP-EAP (Paris) and the Asian Institute of Technology (Bangkok). |
Laurent Nguyen
Partner, Head of Financial Advisory – Vietnam, Member of APAC Financial Advisory Board Forvis Mazars Laurent is an CPA Australia with over 15 years of experience at Forvis Mazars, where he leads the Financial Advisory practice in Vietnam and serves on the APAC Financial Advisory Board. As a CPA, he engages in Deal Advisory including due diligence, valuation, financial modeling, and corporate restructuring. He works across a wide range of industries such as healthcare, infrastructure & energy, manufacturing & industrial, education, consumer goods, TMT, business services. Laurent supports financial and strategic investors and sellers from high-growth startups to established corporates providing actionable insights and hands-on guidance throughout the deal cycle. |
Oanh Nguyen NT(formerly with Clermont, Hoan My) Ms. Oanh has over 8 years of experience in healthcare investment in Vietnam. She previously served as Vice President for Clermont Group – the major shareholder of Hoan My Medical Corporation and later as Project Development Director of FV Hospital. Prior to her healthcare career, she spent nearly 15 years as an investment and M&A professional with various financial institutions in Vietnam, including Red River Holding, Ho Chi Minh City Securities Cooperation, AIG Investments, and Dragon Capital. |


Dr. Su Le
Zig Wronsky
Prithvi Puttaraju
Dao Thu Nga
Laurent Nguyen
Oanh Nguyen NT